Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CERENOME, INC.PSTV · Entity 7637 | Chief Medical Officer | February 22, 2024 | February 26, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CERENOME, INC.
Report date February 22, 2024 · Filed February 26, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.03 · Expires 2034-02-22 | Direct | 24,073 |
Reported balance
After 2024-02-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-02-22 · Grant · Acquired 24,073 · Balance 24,073 F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2024 Filed Feb 26, 2024 23:26 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 24,073 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020418 · ownership.xml · derivative · entry 1 LaFrance Norman D. · CIK 0001397768 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,073 Underlying: Common Stock · 24,073 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance date, and vest upon a change of control event in accordance with the Reporting Person's employment agreement. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:30 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 74,981 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001209191-23-010638 · doc4.xml · derivative · entry 1 LaFrance Norman D. · CIK 0001397768 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,981 Underlying: Common Stock · 74,981 shares Expires 2033-02-15 F1 · derivative.exercise_date: The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance. Read SEC document |
| November 11, 2021 Filed Mar 28, 2022 22:59 UTC Amendment | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (right to buy shares of common stock) · Derivative | 120,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0000899243-22-012518 · doc4a.xml · derivative · entry 1 LaFrance Norman D. · CIK 0001397768 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2031-11-11 F1 · derivative.exercise_date: 25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments. Read SEC document |
| November 01, 2021 Filed Nov 25, 2021 02:09 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (right to buy shares of common stock) · Derivative | 120,000 | $0.00 Strike: $120,000.00 | $0.00 |
DisclosureSEC source: 0000899243-21-046120 · doc4.xml · derivative · entry 1 LaFrance Norman D. · CIK 0001397768 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2031-11-11 F1 · derivative.exercise_date: 25% of the options will vest on November 11, 2022 with the remaining options vesting over the subsequent three years in equal monthly installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.